TECH - 'Ozempic Ftw:' Elon Musk Touts Novo Nordisk's Blockbuster Drug As Solution To Childhood Obesity Problem | Benzinga
Tesla and SpaceX CEO Elon Musk has sparked a conversation about childhood obesity and potential solutions after giving his seal of approval for Novo Nordisk‘s (NYSE:NVO) Ozempic, a GLP-1 agonist primarily prescribed to manage Type 2 diabetes.
What Happened: On Sunday, Musk responded to a post on X about childhood obesity in the U.S. and Japan. The post by Calley Means, co-founder of health startup Truemed, suggested five policies to address the issue, including banning TV pharma ads and reforming agriculture subsidies.
It was re-shared by billionaire investor Bill Ackman, who tagged Joe Biden, Donald Trump, and Robert Kennedy Jr. — the three major presidential candidates for the 2024 elections, saying, “This is great advice.”
Musk responded to Ackman’s post, saying, “Ozempic ftw,” indicating his support for the drug.